-
公开(公告)号:US20090076081A1
公开(公告)日:2009-03-19
申请号:US12207596
申请日:2008-09-10
申请人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Walter Vifian , Xihan Wu
发明人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Walter Vifian , Xihan Wu
IPC分类号: A61K31/445 , C07D211/22 , A61K31/4523 , A61P25/24 , A61P25/16 , C07D401/04
CPC分类号: C07D211/58 , C07D401/04
摘要: The invention relates to a compound of formula wherein Ar1, Ar2, R1, R2, R3, R4, R5, and R5′ or to a pharmaceutically active salt thereof. The compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及下式化合物其中Ar1,Ar2,R1,R2,R3,R4,R5和R5'或其药物活性盐。 这些化合物是用于治疗抑郁症,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。
-
公开(公告)号:US20080306086A1
公开(公告)日:2008-12-11
申请号:US12129718
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , C07D403/02 , C07D217/00 , A61K31/4709 , C07D211/00 , A61K31/454 , A61K31/438 , A61P25/00
CPC分类号: C07D207/16 , C07D401/06 , C07D471/10
摘要: The present invention relates to a compound of formula I wherein R2 R3, R4, R5, X, n, and o are as defined herein and to a pharmaceutically acceptable acid addition salt thereof which are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R2 R3,R4,R5,X,n和o如本文所定义的式I化合物及其药学上可接受的酸加成盐,其为高度潜在的NK-3受体拮抗剂,用于治疗 抑郁症,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)。
-
公开(公告)号:US08618303B2
公开(公告)日:2013-12-31
申请号:US13342122
申请日:2012-01-02
申请人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Walter Vifian
发明人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Walter Vifian
IPC分类号: C07D401/06 , A61K31/445
CPC分类号: C07D401/06 , C07D401/14 , C07D403/06 , C07D407/06 , C07D413/10
摘要: The invention provides compounds of formula wherein R1, R2, R3, R4, R5, and R6 are as defined herein or a pharmaceutically suitable acid addition salt thereof. The present compounds are high potential NK-3 receptor antagonists useful for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明提供下式的化合物,其中R 1,R 2,R 3,R 4,R 5和R 6如本文所定义,或其药学上合适的酸加成盐。 本发明化合物是可用于治疗抑郁症,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。
-
公开(公告)号:US20120178761A1
公开(公告)日:2012-07-12
申请号:US13342122
申请日:2012-01-02
申请人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Walter Vifian
发明人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Walter Vifian
IPC分类号: A61K31/454 , C07D207/14 , A61P25/18 , C07D403/06 , A61K31/501 , C07D401/06 , A61K31/40
CPC分类号: C07D401/06 , C07D401/14 , C07D403/06 , C07D407/06 , C07D413/10
摘要: The invention provides compounds of formula wherein R1, R2, R3, R4, R5, and R6 are as defined herein or a pharmaceutically suitable acid addition salt thereof. The present compounds are high potential NK-3 receptor antagonists useful for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明提供下式的化合物,其中R 1,R 2,R 3,R 4,R 5和R 6如本文所定义,或其药学上合适的酸加成盐。 本发明化合物是可用于治疗抑郁症,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。
-
35.
公开(公告)号:US07592345B2
公开(公告)日:2009-09-22
申请号:US12132002
申请日:2008-06-03
申请人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/497
CPC分类号: C07D295/26 , C07D513/04
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, R4, R9, R10, m and n are as defined herein, or to a pharmaceutically acceptable acid addition salt thereof. The present compounds are high potential NK-3 receptor antagonists for the treatment of depression, bipolar disorders, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R1,R2,R3,R4,R9,R10,m和n如本文所定义的式I化合物或其药学上可接受的酸加成盐。 本发明化合物是用于治疗抑郁症,双相性精神障碍,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。
-
36.
公开(公告)号:US20080312216A1
公开(公告)日:2008-12-18
申请号:US12132002
申请日:2008-06-03
申请人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/551 , C07D513/04 , C07D241/04 , C07D243/08 , A61K31/4985 , A61K31/495
CPC分类号: C07D295/26 , C07D513/04
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, R4, R9, R10, m and n are as defined herein, or to a pharmaceutically acceptable acid addition salt thereof. The present compounds are high potential NK-3 receptor antagonists for the treatment of depression, bipolar disorders, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R1,R2,R3,R4,R9,R10,m和n如本文所定义的式I化合物或其药学上可接受的酸加成盐。 本发明化合物是用于治疗抑郁症,双相性精神障碍,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。
-
37.
公开(公告)号:US07501422B2
公开(公告)日:2009-03-10
申请号:US12129720
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , C07D403/04
CPC分类号: C07D403/12
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, and n are as defined herein or to a pharmaceutically acceptable acid addition salt thereof. These compounds are NK3 receptor antagonists, useful for the treatment of such disorders as depression, pain, bipolar disorders, psychosis, Parkinson's disease, schizophrenia, anxiety, and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R 1,R 2,R 3和n如本文所定义或其药学上可接受的酸加成盐的式I化合物。 这些化合物是NK3受体拮抗剂,可用于治疗抑郁症,疼痛,双相性精神障碍,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)等疾病。
-
38.
公开(公告)号:US20080306089A1
公开(公告)日:2008-12-11
申请号:US12129720
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , C07D403/14 , A61P25/00
CPC分类号: C07D403/12
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, and n are as defined herein or to a pharmaceutically acceptable acid addition salt thereof. These compounds are NK3 receptor antagonists, useful for the treatment of such disorders as depression, pain, bipolar disorders, psychosis, Parkinson's disease, schizophrenia, anxiety, and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R 1,R 2,R 3和n如本文所定义或其药学上可接受的酸加成盐的式I化合物。 这些化合物是NK3受体拮抗剂,可用于治疗抑郁症,疼痛,双相性精神障碍,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)等疾病。
-
公开(公告)号:US08748430B2
公开(公告)日:2014-06-10
申请号:US13478144
申请日:2012-05-23
IPC分类号: A61K31/495
CPC分类号: C07D413/12 , C07D403/12 , C07D413/14 , C07D417/12
摘要: The present invention is concerned with novel sulfonamides of formula I wherein R1, R2, Ar, Hetaryl, m and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.
摘要翻译: 本发明涉及式I的新型磺酰胺,其中R 1,R 2,Ar,杂芳基,m和n如说明书和权利要求中所述。 这些化合物是食欲素受体拮抗剂,可用于治疗食欲素途径参与的病症。
-
公开(公告)号:US07932269B2
公开(公告)日:2011-04-26
申请号:US12353506
申请日:2009-01-14
IPC分类号: A61K31/451 , A61K31/40 , C07D295/192 , C07D211/30
CPC分类号: C07D207/06 , C07D207/08 , C07D211/16
摘要: The present invention is concerned with novel sulfonamides of formula wherein R1, R2, R3 and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.
摘要翻译: 本发明涉及新型的具有下式的磺酰胺,其中R1,R2,R3和n如说明书和权利要求中所述。 这些化合物是食欲素受体拮抗剂,可用于治疗食欲素途径参与的病症。
-
-
-
-
-
-
-
-
-